Ghrelin concentrations in acromegalic patients in relation to the administered therapy

Neuroendocrinology Letters

Volumn 27, Issue 1-2, 2006, Pages 162-168

  Wasko, Ryszard ^a   Jaskula, Magdalena ^a   Komarowska, Hanna ^a   Waligorska Stachura, Joanna ^a   Zamyslowska, Hanna ^a   Sowinski, Jerzy ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Acromegaly; Ghrelin; Long acting octreotide

Indexed keywords

BROMOCRIPTINE; GHRELIN; GROWTH HORMONE; INSULIN; OCTREOTIDE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LONG TERM CARE; MALE; NEUROSURGERY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

EID: 33745647547     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Takaya K, Ariyasu H, Kanamoto N, lwakura H, Yoshimoto A, Harada M, et al. Ghrelin strongly stimulates growth hormone (GH) release in humans. J Clin Endocrinol Metab 2000; 85:4908-11.
2. Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M. Minireview: ghrelin and the regulation of energy balance - a hypothalamic perspective. Endocrinology 2001; 142(10):4163-69.
3. Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002; 56: 203-206.
4. Di Vito L, Broglio F, Benso A, Gottero C, Prodam F, Papotti M et al. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol 2002; 56:643-48.
5. Hataya Y, Akamizu T, Takaya K, Ariyasu NKH, Saijo M, Morijama K et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001; 86(9):4552-55.
6. Norrelund H, Hansen TK, Orskow H, Hosoda H, Kojima M, Kangawa K et al. Ghrelin immunoreactivity in human plasma is suppresses by somatostatin. Clin Endocrinol 2002; 57:539-46.
7. Cappiello V, Ronchi C, Morpurgo PS, Epaminonda P, Arosio M, Beck-Peccoz P et al. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol 2002; 147:189-94.
8. Korbonits M, Bustin SA, Kojima M, Jordan S, Adams EF, Lowe DG et al. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine turnours. J Clin Endocrinol Metab 2001; 86:881-887.
9. Freda PU, Reyes CM, Conwell IM, Sundeen RE, Wardlaw SL. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreoticle therapy. J Clin Endocrinol Metab 2003; 88:2037-44.
10. Barkan AL, Dimaraki EV, Jessup SK, Symons KV, Ermolenko M, Jaffe CA. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 2003; 88:2180-84.
11. Toorn van der FM, Janssen A Herder WW, Broglio F, Ghigo E, Lely der AJ. Central ghrelin production does not substantially contribute to systemic ghrelin concentrations: a study in two subjects with active acromegaly. Eur J Endocrinol 2002; 147:195-99.
12. Saad MF, Bernaba B, Hwu C-M, Jinagouda S, Fahmi S, Kogosov E, et al. Insulin regulates plasma ghrelin concentration, J Clin Endocrinol Metab 2002; 87 (8):3997-4000.
13. Bengtsson BA, Brummer RJ, Eden S, Bosaeus I. Body composition in acromegaly. Clin Endocrinol (Oxf) 1989; 30:121-130.